These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32751370)

  • 21. Eplerenone Treatment in Chronic Central Serous Chorioretinopathy.
    Iqbal F; Iqbal K; Inayat B; Arjumand S; Ghafoor Z; Sattar W; Abbas K
    Cureus; 2021 Oct; 13(10):e18415. PubMed ID: 34729255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.
    Daruich A; Matet A; Marchionno L; De Azevedo JD; Ambresin A; Mantel I; Behar-Cohen F
    Retina; 2017 Oct; 37(10):1905-1915. PubMed ID: 28067724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Coherence Tomography-Based Positive Predictors of Eplerenone Therapy in Chronic Central Serous Chorioretinopathy: A Retrospective Study.
    Sahu V; Nayak S; Kumar A; Kashyap H
    Cureus; 2024 Apr; 16(4):e58791. PubMed ID: 38784343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROL PILOT STUDY OF EPLERENONE FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY (ECSELSIOR).
    Rahimy E; Pitcher JD; Hsu J; Adam MK; Shahlaee A; Samara WA; Vander JF; Kaiser RS; Chiang A; Spirn MJ; Fineman MS
    Retina; 2018 May; 38(5):962-969. PubMed ID: 28426624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy.
    Kwak JH; Hong SW; Ra H; Kim EC; Kang NY; Baek J
    Korean J Ophthalmol; 2019 Dec; 33(6):493-499. PubMed ID: 31833245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Eplerenone in Chronic Central Serous Chorioretinopathy Refractory to Photodynamic Therapy.
    Karagiannis D; Parikakis E; Kontomichos L; Batsos G; Chatziralli I
    Semin Ophthalmol; 2019; 34(6):436-441. PubMed ID: 31309849
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.
    Pichi F; Carrai P; Ciardella A; Behar-Cohen F; Nucci P;
    Int Ophthalmol; 2017 Oct; 37(5):1115-1125. PubMed ID: 27757733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series.
    Salz DA; Pitcher JD; Hsu J; Regillo CD; Fineman MS; Elliott KS; Vander JF; Fischer DH; Spirn MJ
    Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):439-44. PubMed ID: 25970864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.
    Rabiolo A; Zucchiatti I; Marchese A; Baldin G; Sacconi R; Montorio D; Cicinelli MV; Querques L; Bandello F; Querques G;
    Eye (Lond); 2018 Jan; 32(1):55-66. PubMed ID: 29265111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Ketoconazole on the Clinical Recovery in Central Serous Chorioretinopathy.
    Chantarasorn Y; Rasmidatta K; Pokawattana I; Silpa-Archa S
    Clin Ophthalmol; 2022; 16():1871-1882. PubMed ID: 35711967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone.
    Anderson WJ; Smith BT
    Am J Ophthalmol Case Rep; 2022 Dec; 28():101739. PubMed ID: 36393907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
    Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A
    Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous Laser Versus Micropulse Laser in the Treatment of Central Serous Chorioretinopathy: A Retrospective Study.
    Bica M; David A; Balta F; Iacob A
    Cureus; 2024 Feb; 16(2):e53799. PubMed ID: 38465179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in choroidal vascularity in acute central serous chorioretinopathy.
    Rasheed MA; Goud A; Mohamed A; Vupparaboina KK; Chhablani J
    Indian J Ophthalmol; 2018 Apr; 66(4):530-534. PubMed ID: 29582814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
    Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
    Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choroidal thickness in older patients with central serous chorioretinopathy.
    Regatieri CV; Novais EA; Branchini L; Adhi M; Cole ED; Louzada R; Lane M; Reichel E; Duker JS
    Int J Retina Vitreous; 2016; 2():22. PubMed ID: 27847640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy.
    Zola M; Daruich A; Matet A; Mantel I; Behar-Cohen F
    Br J Ophthalmol; 2019 Aug; 103(8):1184-1189. PubMed ID: 30355720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing the episode duration and the anatomical and functional outcome in cases of acute central serous chorioretinopathy.
    Parajuli A; Joshi P
    BMJ Open Ophthalmol; 2020; 5(1):e000540. PubMed ID: 33305002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
    van Rijssen TJ; van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy.
    Shulman S; Goldenberg D; Schwartz R; Habot-Wilner Z; Barak A; Ehrlich N; Loewenstein A; Goldstein M
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):15-22. PubMed ID: 25794988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.